Investor Relation Portal

SYNBIOTIC SE is a leading European corporate group focused on the medical cannabis and industrial hemp markets. Committed to transparency and clarity, our Investor Relation Portal offers comprehensive insights, financial updates, and corporate developments for our shareholders.

SYNBIOTIC

Investor Relation Portal

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat.

Willkommen auf unserem

Investor Relation Portal

Wir vereinen Hanf & Cannabis Unternehmen unter einem Dach,
um Cannabinoide zugänglich zu machen.

ABOUT SYNBIOTIC

SYNBIOTIC SE is a leading European corporate group focused on the dynamic development of the medical cannabis and industrial hemp markets.

As a public listed company, SYNBIOTIC SE offers its investors the opportunity to capitalise on the strong growth potential of these highly regulated and rapidly expanding markets.

Our group strategically invests in promising ventures across the entire value chain – from cultivation and research to development, production, sales, and distribution of premium cannabinoid-based products. By integrating majority-owned companies, we ensure rigorous quality management throughout all production processes and the supply chain – a unique strength in the industry.

Through our successful buy-and-build strategy, we continuously expand our operations and strengthen our innovation-driven platform, setting new standards in the market.

SYNBIOTIC – Your Smartest Way to Invest in Medical Cannabis and Industrial Hemp.

more about synbiotic
+ 10
companies

joined our Platform

80+
WORKING TALENTS

to fulfill our Vision

Welcome to our
Investor Relations Portal

We unlock the power of cannabinoids to heal modern world diseases.

About the Stock

WKN:

A3E5A5

Ticker Symbol:

SBX

ISIN:

DE000A3E5A59

Shareholder Structure:

63 % Management & Founders

23 % other Institutionals

11 % Freefloat

Aktionärsstruktur:

Management & Founders ca. 71%

Institutional & Retail Shareholders ca. 29%

Stock Exchange:

Xetra, Düsseldorf, Tradegate, GETTEX

Total number of shares:

7.992.259,00

Share capital:

7.992.259,00

Downloads

Corporate Presentations​

Annual General Meetings

Annual General Meeting on August 05, 2021.

The Annual General Meeting of SynBiotic SE took place on Thursday, August 5, 2021, at 10:00 a.m. (CEST).

The Company's Annual General Meeting was held as a virtual general meeting without the physical presence of shareholders or their proxies (except for the Company's proxies).

Additional to Top 9:

There were no countermotions.

June 2026: Data sheet Düsseldorf Stock Exchange

June 2026: Financial calendar 2026 - Update

March 2026: Data sheet Düsseldorf Stock Exchange

March 2026: Company agreement - Satzung - SYNBIOTIC SE

February 2026: Data sheet Düsseldorf Stock Exchange

February 2026: Financial calendar 2026 - Update

November 2025: Financial calendar 2025 -Update

September 2025: Data sheet Düsseldorf Stock Exchange

October 2025: Data sheet Düsseldorf Stock Exchange

September 2025: Company agreement - Satzung - SYNBIOTIC SE

July 2025: Company agreement - Satzung - SYNBIOTIC SE

June 2025: Financial calendar 2025 -Update

December 2024: Data sheet Düsseldorf Stock Exchange

December 2024: Financial calendar 2024 -Update

November 2024: Company agreement - Satzung - SYNBIOTIC SE

July 2024: Financial calendar 2024 -Update

May 2024: Data sheet Düsseldorf Stock Exchange

May 2024: Financial calendar 2024 -Update

March 2024: Basic Information Sheet of the Convertible Bond March 2024

March 2024: Convertible Bond Conditions of the Convertible Bond March 2024/2025

Exercise declaration convertible bond: August 2023/2025 (ISIN DE000A351VJ4)

December 2023: Financial calendar 2024

August 2023: Securities Information Sheet- Update as of 25 August 2023

August 2023: Securities Information Sheet dated 20 August 2023

August 2023: Basic Information Sheet of the Convertible Bond August 2023/2025

August 2023: Convertible Bond Conditions of the Convertible Bond August 2023/2025

October 2021: Securities Information Sheet pursuant to § 4 of the German Securities Prospectus Act ("WpPG")

December 2020: Securities Prospectus

    • 04/2026 | Annual General Meeting 2025 (23 April 2026)
      09/2026 | Consolidated Annual Financial Statements 2025 (HGB)
      09/2026 | Annual Financial Statements of SYNBIOTIC SE 2025 (HGB)
      09/2026 | Annual General Meeting 2026
      09/2026 | Half Year Individual Financial Statements of SYNBIOTIC SE 2026 (HGB)

Meet us

Meet us in person at premier hemp and cannabis exhibitions.

Stand/ SPEAKER SLOT

Datum

Link

ExHIBITION

ICBC - International Cannabis and Business Conference, ESTREL Hotel Berlin

SynBiotic appears cautiously valued

internationalcbc.com/
13.-15. April 2027

Analysts

Recommendation

Target Price

Last Research

Analyst

October 2021
75 EURO
BUY

Hauck & Aufhäuser

When time meets opportunity; initiate with a BUY

July 2021
INITIATION

Edison Investment Research

SynBiotic appears cautiously valued

March 2022
47 Euro
BUY

Alster Research

Strong founder and owner network that has proven how to scale a platformcompany

December 2021
42,50 EURO
BUY

Baader Bank

Unsere Geschäftsbereiche

Medicinal cannabis used for therapeutic applications with patients.
Our industrial hemp is used to manufacture sustainable products across various industries.
High-quality products for home cultivation. Up to 4,000 products in the range.